[1]
|
Kaur, G., Lungarella, G. and Rahman, I. (2020) SARS-CoV-2 COVID-19 Susceptibility and Lung Inflammatory Storm by Smoking and Vaping. Journal of Inflammation, 17, Article No. 21. https://doi.org/10.1186/s12950-020-00250-8
|
[2]
|
Alqahtani, J.S., Oyelade, T., Aldhahir, A.M., Alghamdi, S.M., Almehmadi, M., Alqahtani, A.S., et al. (2020) Prevalence, Severity and Mortality Associated with COPD and Smoking in Patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PLoS ONE, 15, e0233147. https://doi.org/10.1371/journal.pone.0233147
|
[3]
|
Lang, A.E. and Yakhkind, A. (2020) Coronavirus Disease 2019 and Smoking: How and Why We Implemented a Tobacco Treatment Campaign. Chest, 158, 1770-1776. https://doi.org/10.1016/j.chest.2020.06.013
|
[4]
|
Archie, S.R. and Cucullo, L. (2020) Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping? International Journal of Molecular Sciences, 21, Article No. 3916. https://doi.org/10.3390/ijms21113916
|
[5]
|
Farsalinos, K., Barbouni, A., Poulas, K., Polosa, R., Caponnetto, P. and Niaura, R. (2020) Current Smoking, Former Smoking, and Adverse Outcome among Hospitalized COVID-19 Patients: A Systematic Review and Meta-Analysis. Therapeutic Advances in Chronic Disease, 11, Article ID: 2040622320935765. https://doi.org/10.1177%2F2040622320935765
|
[6]
|
Zheng, Z., Peng, F., Xu, B., Zhao, J., Liu, H., Peng, J., et al. (2020) Risk Factors of Critical & Mortal COVID-19 Cases: A Systematic Literature Review and Meta-Analysis. Journal of Infection, 81, e16-e25. https://doi.org/10.1016/j.jinf.2020.04.021
|
[7]
|
Emami, A., Javanmardi, F., Pirbonyeh, N. and Akbari, A. (2020) Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis. Archives of Academic Emergency Medicine, 24, Article No. e35. https://pubmed.ncbi.nlm.nih.gov/32232218/
|
[8]
|
van Zyl-Smit, R.N., Richards, G. and Leone, F.T. (2020) Tobacco Smoking and COVID-19 Infection. The Lancet Respiratory Medicine, 8, 664-665. https://doi.org/10.1016/s2213-2600(20)30239-3
|
[9]
|
Hopkinson, N.S., Rossi, N., El-Sayed, M.J., Laverty, A.A., Quint, J.K., Freidin, M., et al. (2021) Current Smoking and COVID-19 Risk: Results from a Population Symptom App in over 2.4 Million People. Thorax, 76, 714-722. http://doi.org/10.1136/thoraxjnl-2020-216422
|
[10]
|
Jackson, S.E., Brown, J., Shahab, L., Steptoe, A. and Fancourt, D. (2020) COVID-19, Smoking and Inequalities: A Study of 53002 Adults in the UK. Tobacco Control, 1, Article ID: tobaccocontrol-2020-055933.
|
[11]
|
Umnuaypornlert, A., Kanchanasurakit, S., Lucero-Prisno, D.E.I. and Saokaew, S. (2021) Smoking and Risk of Negative Outcomes among COVID-19 Patients: A Systematic Review and Meta-Analysis. Tobacco Induced Diseases, 19, Article No. 9. https://doi.org/10.18332/tid/132411
|
[12]
|
Wang, Y., Xu, J., Meng, Y., Adcock, I.M. and Yao, X. (2018) Role of Inflammatory Cells in Airway Remodeling in COPD. International Journal of Chronic Obstructive Pulmonary Disease, 13, 3341-3348. https://doi.org/10.2147/COPD.S176122
|
[13]
|
McGuinness, A.J. and Sapey, E. (2017) Oxidative Stress in COPD: Sources, Markers, and Potential Mechanisms. Journal of Clinical Medicine, 6, Article No. 21. https://doi.org/10.3390/jcm6020021
|
[14]
|
Hikichi, M., Mizumura, K., Maruoka, S. and Gon, Y. (2019) Pathogenesis of Chronic Obstructive Pulmonary Disease (COPD) Induced by Cigarette Smoke. Journal of Thoracic Disease, 11, S2129-S2140. https://doi.org/10.21037/jtd.2019.10.43
|
[15]
|
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., et al. (2020) Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. The Journal of the American Medical Association, 323, 1061-1069. https://doi.org/10.1001/jama.2020.1585
|
[16]
|
Graham, B.L., Steenbruggen, I., Miller, M.R., Barjaktarevic, I.Z., Cooper, B.G., Hall, G.L., et al. (2019) Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. American Journal of Respiratory and Critical Care Medicine, 200, e70-e88. https://doi.org/10.1164/rccm.201908-1590st
|
[17]
|
Leung, J.M., Yang, C.X., Tam, A., Shaipanich, T., Hackett, T.-L., Singhera, G.K., et al. (2020) ACE-2 Expression in the Small Airway Epithelia of Smokers and COPD Patients: Implications for COVID-19. European Respiratory Journal, 55, Article ID: 2000688. https://doi.org/10.1183/13993003.00688-2020
|
[18]
|
Russo, P., Bonassi, S., Giacconi, R., Malavolta, M., Tomino, C. and Maggi, F. (2020) COVID-19 and Smoking: Is Nicotine the Hidden Link? European Respiratory Journal, 55, Article ID: 2001116. https://doi.org/10.1183/13993003.01116-2020
|
[19]
|
Farsalinos, K., Angelopoulou, A., Alexandris, N. and Poulas, K. (2020) COVID-19 and the Nicotinic Cholinergic System. European Respiratory Journal, 56, Article ID: 2001589. https://doi.org/10.1183/13993003.01589-2020
|
[20]
|
Leung, J.M., Yang, C.X. and Sin, D.D. (2020) COVID-19 and Nicotine as a Mediator of ACE-2. European Respiratory Journal, 55, Article ID: 2001261. https://doi.org/10.1183/13993003.01261-2020
|
[21]
|
Salah, H.M., Sharma, T. and Mehta, J. (2020) Smoking Doubles the Mortality Risk in COVID-19: A Meta Analysis of Recent Reports and Potential Mechanisms. Cureus, 12, Article ID: e10837. https://doi.org/10.7759/cureus.10837
|
[22]
|
Zhang, C., Zhao, W., Li, J.-W., Zhao, H. and Wang, G.-Q. (2020) The Cytokine Release Syndrome (CRS) in Severe COVID-19: Interleukin-6 Receptor Antagonist Tocilizumab May Be the Key to Reduce Mortality. International Journal of Antimicrobial Agents, 55, Article ID: 105954. https://doi.org/10.1016/j.ijantimicag.2020.105954
|
[23]
|
Shimizu, M. (2019) Clinical Features of Cytokine Storm Syndrome. In: Cron, R.Q. and Behrens, E.M., Eds., Cytokine Storm Syndrome, Springer International Publishing, Cham, 31-41. https://doi.org/10.1007/978-3-030-22094-5_3
|
[24]
|
Saeed, R.W., Varma, S., Peng-Nemeroff, T., Sherry, B., Balakhaneh, D., Huston, J., et al. (2005) Cholinergic Stimulation Blocks Endothelial Cell Activation and Leukocyte Recruitment during Inflammation. The Journal of Experimental Medicine, 201, 1113-1123. https://doi.org/10.1084/jem.20040463
|
[25]
|
Alexandris, N., Lagoumintzis, G., Chasapis, C.T., Leonidas, D.D., Papadopoulos, G.E., et al. (2021) Nicotinic Cholinergic System and COVID-19: In Silico Evaluation of Nicotinic Acetylcholine Receptor Agonists as Potential Therapeutic Interventions. Toxicology Reports, 8, 73-83. https://doi.org/10.1016/j.toxrep.2020.12.013
|
[26]
|
Li, W., Moore, M.J., Vasilieva, N., Sui, J., Wong, S.K., et al. (2003) Angiotensin-Converting Enzyme 2 Is a Functional Receptor for the SARS Coronavirus. Nature, 426, 450-454. https://doi.org/10.1038/nature02145
|
[27]
|
Farsalinos, K., Barbouni, A. and Niaura, R. (2020) Systematic Review of the Prevalence of Current Smoking among Hospitalized COVID-19 Patients in China: Could Nicotine Be a Therapeutic Option? Internal and Emergency Medicine, 15, 845-852. https://doi.org/10.1007/s11739-020-02355-7
|
[28]
|
Wrapp, D., Wang, N., Corbett, K.S., Goldsmith, J.A., Hsieh, C.-L., Abiona, O., et al. (2020) Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation. Science, 367, 1260-1263. https://doi.org/10.1126/science.abb2507
|
[29]
|
Roth, M.D., Arora, A., Barsky, S.H., Kleerup, E.C., Simmons, M. and Tashkin, D.P. (1998) Airway Inflammation in Young Marijuana and Tobacco Smokers. American Journal of Respiratory and Critical Care Medicine, 157, 928-937. https://doi.org/10.1164/ajrccm.157.3.9701026
|
[30]
|
Tsujii, M., Iijima, H., Nishida, T. and Takehara, T. (2013) Smoking and Alimentary Diseases. Nihon Rinsho (Japanese Journal of Clinical Medicine), 71, 436-442.
|
[31]
|
Rouse, R.L., Boudreaux, M.J. and Penn, A.L. (2007) In Utero Environmental Tobacco Smoke Exposure Alters Gene Expression in Lungs of Adult BALB/c Mice. Environmental Health Perspectives, 115, 1757-1766. https://doi.org/10.1289/ehp.10358
|
[32]
|
Takubo, Y., Guerassimov, A., Ghezzo, H., Triantafillopoulos, A., Bates, J.H.T., Hoidal, J.R., et al. (2002) α1-Antitrypsin Determines the Pattern of Emphysema and Function in Tobacco Smoke-Exposed Mice: Parallels with Human Disease. American Journal of Respiratory and Critical Care Medicine, 166, 1596-1603. https://doi.org/10.1164/rccm.2202001
|
[33]
|
Churg, A., Wang, R.D., Tai, H., Wang, X., Xie, C., Dai, J., et al. (2003) Macrophage Metalloelastase Mediates Acute Cigarette Smoke-Induced Inflammation via Tumor Necrosis Factor-α Release. American Journal of Respiratory and Critical Care Medicine, 167, 1083-1089. https://doi.org/10.1164/rccm.200212-1396OC
|
[34]
|
Fiorentino, D.F., Zlotnik, A., Mosmann, T.R., Howard, M. and O’Garra, A. (1991) IL-10 Inhibits Cytokine Production by Activated Macrophages. The Journal of Immunology, 147, 3815-3822.
|
[35]
|
Hosseinzadeh, A., Thompson, P.R., Segal, B.H. and Urban, C.F. (2016) Nicotine Induces Neutrophil Extracellular Traps. Journal of Leukocyte Biology, 100, 1105-1112. https://doi.org/10.1189/jlb.3AB0815-379RR
|
[36]
|
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D.S., et al. (2004) Neutrophil Extracellular Traps Kill Bacteria. Science, 303, 1532-1535. https://doi.org/10.1126/science.1092385
|
[37]
|
Montalvan, V., Lee, J., Bueso, T., De Toledo, J. and Rivas, K. (2020) Neurological Manifestations of COVID-19 and Other Coronavirus Infections: A Systematic Review. Clinical Neurology and Neurosurgery, 194, Article ID: 105921. https://doi.org/10.1016/j.clineuro.2020.105921
|
[38]
|
Klein, R.S., Garber, C. and Howard, N. (2017) Infectious Immunity in the Central Nervous System and Brain Function. Nature Immunology, 18, 132-141. https://doi.org/10.1038/ni.3656
|
[39]
|
Sajja, R.K., Naik, P. and Cucullo, L. (2015) Differential Cerebrovascular Toxicity of Various Tobacco Products: A Regulatory Perspective. Journal of Pharmacovigilance, 3, Article No. e130. https://doi.org/10.4172/2329-6887.1000e130
|
[40]
|
Kaisar, M.A., Villalba, H., Prasad, S., Liles, T., Sifat, A.E., Sajja, R.K., et al. (2017) Offsetting the Impact of Smoking and E-Cigarette Vaping on the Cerebrovascular System and Stroke Injury: Is Metformin a Viable Countermeasure? Redox Biology, 13, 353-362. https://doi.org/10.1016/j.redox.2017.06.006
|
[41]
|
Sifat, A.E., Vaidya, B., Kaisar, M.A., Cucullo, L. and Abbruscato, T.J. (2018) Nicotine and Electronic Cigarette (E-Cig) Exposure Decreases Brain Glucose Utilization in Ischemic Stroke. Journal of Neurochemistry, 147, 204-221. https://doi.org/10.1111/jnc.14561
|
[42]
|
Mao, L., Wang, M., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., Jin, H. and Hu, B. (2020) Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: A Retrospective Case Series Study. medRxiv. https://doi.org/10.1101/2020.02.22.20026500
|